Certuity LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 45.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,932 shares of the medical equipment provider’s stock after purchasing an additional 602 shares during the period. Certuity LLC’s holdings in Intuitive Surgical were worth $1,008,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of ISRG. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management raised its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its holdings in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities research analysts have issued reports on ISRG shares. Leerink Partners boosted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.
Intuitive Surgical Stock Down 0.7 %
Shares of NASDAQ:ISRG opened at $591.65 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market cap of $210.73 billion, a P/E ratio of 92.30, a P/E/G ratio of 5.67 and a beta of 1.39. The company’s 50-day moving average price is $555.91 and its two-hundred day moving average price is $515.92.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,348 shares of company stock worth $3,587,582. Company insiders own 0.90% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- The How and Why of Investing in Gold Stocks
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What Investors Need to Know About Upcoming IPOs
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Energy and Oil Stocks Explained
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.